Please contact our sales representative to learn more information about this reagents.
Background
Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.